Nastascia Phillips

Associate, New York



Nastascia is an associate in the Mergers & Acquisitions Practice Group, and is resident in the New York office. Nastascia represents corporate clients and private equity funds in domestic and global mergers, acquisitions and equity investments in a broad range of industries.

Bars and Courts
New York State Bar
Harvard Law School
Pace University


Representation of Elevance Health, Inc. (NYSE: ELV) (f/k/a Anthem, Inc.), one of the nation's leading healthcare companies in its acquisition of Blue Cross and Blue Shield of Louisiana (BCBSLA), a Louisiana mutual insurance company.

Representation of Elevance Health, Inc. in its acquisition of Integra MLTC, Inc., a managed health care plan providing long-term care to individuals and communities in New York.

Representation of Sole Source Capital, an industrial-focused private equity firm, on the merger of Peak Technologies, one of the leading multinational system integrators in the Automatic Identification and Data Capture market, and Supply Chain Services, a leading full lifecycle system integrator and provider of digital supply chain, retail and mobile workforce solutions.

Representation of Soaring Eagle Acquisition Corp. (NASDAQ: SRNG), a SPAC, in its US$15 billion business combination with Ginkgo Bioworks, Inc., a synthetic biology company, which uses technology to program cells for a potentially wide variety of uses, including fragrances and sweeteners, as well as mRNA vaccines and animal-free proteins.

Representation of NTT DATA, Inc., a recognized leader in global information technology services, in its acquisition of Nexient, LLC, a US-based software services firm.

Representation of Quad-C Management, Inc., a private equity firm, in its acquisition of Village Gourmet Holdco, LLC and its subsidiaries, specialty producers of fine meat and snacking options.

Representation of DFP Healthcare Acquisitions Corp. (NASDAQ: DFPH, DFPHW), a SPAC, in its US$842 million business combination with The Oncology Institute, a US market-leader in value-based oncology care.